Please login to the form below

Not currently logged in
Email:
Password:

Mereo BioPharma appoints CFO

Richard Jones joins the rare diseases specialist

London, UK-based Mereo BioPharma Group has appointed Richard Jones as chief financial officer and member of the board of directors, effective from early 2017.

Jones joins the rare and specialty diseases clinical-stage company from Shield Therapeutics, where he most recently served as chief financial officer and company secretary.

Prior to this, Jones worked in investment banking and specialised in advising healthcare clients. He held a number of senior positions as Brewin Dolphin Securities, Investec and PricewaterhouseCoopers.

Dr Denise Scots-Knight, chief executive of Mereo BioPharma, said: “I am delighted to announce the appointment of Richard Jones as our chief financial officer and to the board of directors.

“His extensive financial experience in healthcare industry, initially as an investment banker in the sector and more recently as chief financial officer of Shield Therapeutic, complements that of the other members of Mereo's executive team.

“Following our positive debut as a listed company, the board is confident that Richard will make a valuable and significant contribution to Mereo's future success.”

21st November 2016

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
ROAD

ROAD is a digital PR and communications consultancy specialising in promoting the innovators that shape our future health and wellbeing....

Latest intelligence

Numbers, navigation, and narratives: digital storytelling in medical communications
Science and storytelling aren’t often seen as compatible. One is based on cold, hard facts, while the other is synonymous with improvisation and theater. However, when done well, storytelling can...
Is this common data mistake killing your digital patient recruitment?
Without realising, you could be falling into the trap of using social data — insights into recent, relevant trends and topics — to inspire your content. Hold up. That sounds...
Dr Henry Skinner
The AMR Action Fund is combating antimicrobial resistance, but much more action is needed
By Henry Skinner, Chief Executive Officer of the AMR Action Fund...